Quick Answer
TuHURA Biosciences, Inc./NV reported R&D Expense of $20.53 million for fiscal year 2025.
TuHURA Biosciences, Inc./NV R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $20.53M | +54.0% |
| 2024 | $13.34M | +400.8% |
| 2024 | $2.66M | -71.7% |
| 2023 | $9.40M | +1.0% |
| 2023 | $9.31M | -38.6% |
| 2022 | $15.17M | +28.4% |
| 2021 | $11.81M | +225.5% |
| 2020 | $3.63M | -0.9% |
| 2019 | $3.66M | +151.3% |
| 2018 | -$7.13M | -42.6% |
| 2017 | -$5.00M | -248.9% |
| 2016 | $3.36M | +231.5% |
| 2015 | -$2.56M | -20.6% |
| 2014 | -$2.12M | -190.5% |
| 2013 | $2.34M | +51.1% |
| 2012 | $1.55M | +47.5% |
| 2011 | $1.05M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.97M | +68.6% | +0.8% |
| June 30, 2025 | $4.93M | +74.5% | +7.5% |
| March 31, 2025 | $4.58M | +27.7% | +55.5% |
| September 30, 2024 | $2.95M | +58.5% | +4.4% |
| June 30, 2024 | $2.82M | — | -21.3% |
| March 31, 2024 | $3.59M | +79.0% | +3133.3% |
| December 31, 2023 | $111.0K | -94.6% | -94.0% |
| September 30, 2023 | $1.86M | -41.4% | -7.3% |
- TuHURA Biosciences, Inc./NV showed an increase of +54.0% in R&D Expense compared to the prior fiscal year.
- Over the 2011–2025 period, TuHURA Biosciences, Inc./NV’s r&d expense has grown by 1853.4% (from $1.05 million to $20.53 million).
- The most recent figure is from TuHURA Biosciences, Inc./NV’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: